The National Authority for Medicines and Health Products (Infarmed) decided to ban the export of 51 medications. The measure aims to guarantee the supply of the Portuguese internal market, particularly during a period of scarcity of certain drugs. This decision comes in a context of growing concerns about the availability of essential medicines for patients in Portugal.
The list of medications covered by the ban takes effect from Tuesday. The medications included in this measure were subject to specific export restrictions, as they were identified as essential for domestic consumption. Infarmed considers that the export of these products could compromise Portuguese access to necessary treatments.
The Portuguese regulatory authority has been closely monitoring the situation of the national pharmaceutical market. This is not the first time Infarmed has taken this type of measure to protect domestic supply, but the extent of the list of medications banned from export highlights the severity of current concerns. Economic operators in the pharmaceutical sector must comply with the new rules from the effective date.
